Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of SAR441566 compared to placebo for adults with moderate to severe Crohn’s disease

    Not recruiting

    2 1
    Investigated Diseases:
    Bulgaria Croatia Czechia France Germany Hungary +5
  • Study on the Safety and Effectiveness of Adalimumab as Initial Treatment for Newly Diagnosed Crohn’s Disease Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    Austria Denmark Germany Italy Poland Spain
  • Study on Risankizumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    Czechia Hungary Lithuania Poland
  • Study on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Germany Hungary Italy Poland Spain
  • Study on Guselkumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Croatia Czechia France Germany Hungary Italy +4
  • Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1 1
    Investigated Drugs:
    Belgium Croatia Czechia France Germany Hungary +7
  • Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Greece Hungary +5
  • Study on the Safety and Effects of Tulisokibart for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Poland
  • Study on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +9